We updated the design of this site on December 18, 2017. Learn more.
ClinicalTrials.gov Menu

The Study Of CT Scans and Echo Parameters in Patients With PAH

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT00625963
Recruitment Status : Completed
First Posted : February 29, 2008
Last Update Posted : July 30, 2013
Information provided by (Responsible Party):

Study Description
Brief Summary:
Current standard of the diagnosis and monitoring of PHNT requiring combination of invasive and non-invasive tests. The goal of the study is to correlate data from CT scans, echocardiograms, right heart catheterization, PFTs, sleep studies, and perfusion scans. The ultimate goal is to determine patterns of the PAH disease processes.

Condition or disease
Pulmonary Hypertension

Detailed Description:
The goal of our study is to correlate data from various non-invasive tests such as commuted tomography (CT) imaging, echocardiogram, Pulmonary Function Tests, and other laboratory tests along with hemodynamic measurements from Right Heart Catheterizations in these ILD patients with Pulmonary Hypertension, as well as all other pulmonary hypertension. The ultimate goal is to determine patterns of the PAH disease processes, as well as define optimal diagnostic modalities including in-hospital verses outpatient studies.

Study Design

Study Type : Observational
Actual Enrollment : 71 participants
Observational Model: Cohort
Time Perspective: Retrospective
Official Title: The Study of CT Scan and Echocardiogram Parameters in Patients With Pulmonary Hypertension With Regards to Hemodynamics, Sleep Studies, and Various Laboratory Markers.
Study Start Date : April 2007
Primary Completion Date : June 2008
Study Completion Date : July 2011

Resource links provided by the National Library of Medicine

U.S. FDA Resources

Groups and Cohorts

I=Pulmonary Hypertension Patients A=ILD patients with Pulmonary Hypertension Patients

Outcome Measures

Primary Outcome Measures :
  1. The Study Of CT Scans and Echo Parameters in Patients With PAH [ Time Frame: All data has been previously collected. ]
    Correlation of Pulmonary artery diameter as measured by CT scan and Pulmonary artery systolic pressure as measured by Echocardiogram.

Eligibility Criteria

Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.

Ages Eligible for Study:   18 Years to 80 Years   (Adult, Senior)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No
Sampling Method:   Non-Probability Sample
Study Population
Pulmonary Arterial Hypertension; Idiopathic Lung Disease

Inclusion Criteria:

  • Pulmonary Hypertension;
  • ILD with Pulmonary Hypertension

Exclusion Criteria:

  • NON-PH
Contacts and Locations

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT00625963

United States, New York
North Shore-Long Island Jewish Health System
New Hyde Park, New York, United States, 11040
Sponsors and Collaborators
Northwell Health
Principal Investigator: Arunabh Talwar, MD Northwell Health
More Information

Responsible Party: Northwell Health
ClinicalTrials.gov Identifier: NCT00625963     History of Changes
Other Study ID Numbers: 07.060
First Posted: February 29, 2008    Key Record Dates
Last Update Posted: July 30, 2013
Last Verified: July 2013

Keywords provided by Northwell Health:
Pulmonary Hypertension;
CT Imaging;
Hemodynamic measurements of RHC.
Pulmonary Function Tests

Additional relevant MeSH terms:
Hypertension, Pulmonary
Vascular Diseases
Cardiovascular Diseases
Lung Diseases
Respiratory Tract Diseases